Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus

NCT01408199 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Lupus

Interventions

DRUG: Lenalidomide

Sponsor

Hospital Universitari Vall d'Hebron Research Institute